SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-12-347832
Filing Date
2012-08-09
Accepted
2012-08-09 16:56:03
Documents
4
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q d394051d10qa.htm 10-Q/A 84677
2 ROYALTY BEARING LICENSE AGREEMENT AND SUPPLY AGREEMENT d394051dex1011.htm EX-10.11 414081
3 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) d394051dex313.htm EX-31.3 3640
4 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) d394051dex314.htm EX-31.4 3645
  Complete submission text file 0001193125-12-347832.txt   507116
Mailing Address 45 FITZWILLIAM SQUARE DUBLIN L2 2
Business Address 45 FITZWILLIAM SQUARE DUBLIN L2 2 353-1-634-4183
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33500 | Film No.: 121021082
SIC: 2834 Pharmaceutical Preparations